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ELSEVIER 
Tacrolimus Enhances the Immunosuppressive Effect of 
Cyclophosphamide But Not That of Leflunomide or Mycophenolate 
mofetil in a Model of Discordant Liver Xenotransplantation 
T. Miki, A. Goller, A. Rao, X. Wang, W-Y. Yin, A. Tandin, J.J. Fung, T.E. Starzl, and L.A. Valdivia 
L EFLUNOMIDE (LEF), which suppresses both T and B cells, prolongs survival of heart xenografts in the 
concordant hamster to rat animal model. l However, xeno-
transplantation across discordant barriers is the most likely 
approach to solve the problem of organ shortage. By 
perfusing guinea pig livers with University of Wisconsin 
solution containing sodium nitroprusside, we have solved 
the problem of poor reperfusion of this organ when trans-
planted into rats.2 Accordingly, we tested the effect of LEF 
alone or in combination with tacrolimus (PK.) on survival of 
guinea pig to rat liver xenografts. Results were compared 
with those obtained following the use of cyclophosphamide 
(CyP) and mycophenolate mofetil (MMF). 
MATERIALS AND METHODS 
Animals 
Hartley guinea pigs weighing 200 to 250 g were used as liver donors 
and Lewis rats weighing 200 to 270 g were the recipients. 
Liver Transplantation 
The cuff technique was used for the orthotopic procedure with one 
difference; the cuff for the infrahepatic inferior vena cava (IYC) 
anastomosis was placed in the rat recipient and afterward inserted 
into the infrahepatic IYC of the donor liver. 
Immunosuppression 
Rat recipients received 80 Ulkg cobra venom factor (CVF) from 
day -1 to day + 2 post-Tx. LEF was given at a dose of 10, IS, and 
30 mg/kg per day from day -1 until rejection. Eighty mg/kg CyP 
was given as a single intravenous injection 10 days before Tx. MMF 
and FK were used at a dose of 10 and 1 mg/kg per day, respectively, 
from day -1 onwards. Antibody formation and total hemolytic 
complement (CH50) were measured in xenograft recipients. 
RESULTS AND DISCUSSION 
As shown in Table I, untreated liver xenografts underwent 
hyperacute rejection within 4 h (group I). CVF alone 
prolonged animal survival to a mean of 26 h (group II); an 
effect that was doubled by MMF (group V) and LEF (group 
VI). It was interesting that although CyP did not enhance 
the effect of CVF (group IV), the addition of PK. resulted in 
4 of 10 recipients surviving for up to 1 week post-Tx (group 
VII). Contrarily, the addition of FK to MMF (group VIII) 
or LEF (group IX-XI) did not result in further prolonga-
tion of recipient survival. Needless to say, the absence of 
CVF in any immunosuppressive cocktail resulted in hyper-
acute rejection in a few hours. Hemorrhagic gastritis was 
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Table 1. Survival of Guinea Plg-to-Rat Liver Xenograft Recipients Immunosuppressed With CVF, Tacrolimus, CyP, LEF, or MMF 
Group N Treatment 
10 None 
II 5 CVF 
III 4 CVF + FK 1 mg 
IV 5 CVF + CyP 80 mg 
V 5 CVF + MMF 10 mg 
VI 4 CVF + LEF 15 mg 
VII 10 CVF + FK + CyP 80 mg 
VIII 5 CVF + FK + MMF 10 mg 
IX 4 CVF + FK + LEF 10 mg 
X 5 CVF + FK + LEF 15 mg 
XI 5 CVF + FK + LEF 30 mg 
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Recipient Survival 
(h) (Mean :!: SO) 
3.1 ± 1.7 
26.2 ± 12.2 
20.7 ± 1.2 
28.6 ± 14.3 
49.4 ± 2.7 
59.7 ± 13.1 
110.7 ± 48.3 
55.8 ± 8.8 
36.0 ± 16.9 
62.5 ± 31.3 
35.6 ± 9.8 
p 
<.001 vs GI 
NS vs Gil 
<.01 vs Gil 
<.01 vs Gil 
<.0001 vs all 
NS vs GV 
NS vs GVI, IX 
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universally observed in animals receiving LEF. It is possible 
that the guinea pig liver. as has been described in the dog, 
may have a genetic deficiency to acetylate, an aniline 
metabolite of LEF, leading to the appearance of toxic 
effects. 3 While xenoreactive natural antibodies became un-
detectable following Tx, and despite the use of immunosup-
pression, elevated titers of circulating antibodies were ob-
served from post-Tx day 2; at the time when most 
xenografts were rejected. Liver rejection occurred in the 
absence of complement. which returned to normal levels by 
post-Tx day 7. Liver function tests in long-surviving recipi-
ents were relatively normal and histopathologic analysis of 
their livers revealed minimal or no signs of vascular injury. 
MIKI. GOLLER, RAO ET AL 
In conclusion. tacrolimus enhances the immunosuppressive 
effect of CyP and prolongs survival of guinea pig to rat liver 
xenograft recipients receiving eVF. This effect of tacroli-
mus is not evident with LEF or MMF. 
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